US › Healthcare

Anebulo Pharmaceuticals Inc (ANEB)

US · Healthcare · Biotechnology

$0.32-3.03%
Last close · 2026-08-04

Key statistics

Market cap
$13.1M
Forward P/E
0.0
P/B
1.70
Book value
$0.19
EPS (TTM)
$-0.18
52-week high
$2.90
52-week low
$0.00
50-day MA
$0.38
200-day MA
$1.05
Beta
-1.82

Analyst view

Analysts rate Anebulo Pharmaceuticals Inc a strong buy (2 buy, 0 hold, 0 sell out of 2) with an average price target of $3.00.

Shareholding

Insiders
40.84%

Largest institutional holders

FundStake
Vanguard Group Inc1.07%
Royal Bank of Canada0.00%
22NW, LP0.00%
State Street Corp0.00%
Ikarian Capital, LLC0.00%
BlackRock Inc0.00%
Tower Research Capital LLC0.00%
Northern Trust Corp0.00%

See the full picture

Technicals, trade setups with a published hit rate, $AI analysis and earnings-call summaries for Anebulo Pharmaceuticals Inc — free to start.

Google PlayApp Store

Other Healthcare companies

Eli Lilly and CompanyJohnson & JohnsonAbbVie IncUnitedHealth Group IncorporatedMerck & Company IncNovartis AG ADRAstraZeneca PLCThermo Fisher Scientific IncNovo Nordisk A/SAmgen IncAbbott LaboratoriesGilead Sciences Inc

Data updated 2026-08-05.